NewGenIvf Provides Update on Potential Reverse Merger with COVIRIX - StockTitan
| NIVFW Stock | 0.05 0.01 18.50% |
Slightly above 56% of all NewGenIvf Group's sophisticated investors are looking to take a long position. The analysis of the overall prospects from investing in NewGenIvf Group Limited suggests that some traders are, at the present time, interested. NewGenIvf Group's investing sentiment can be driven by a variety of factors including economic data, NewGenIvf Group's earnings reports, geopolitical events, and overall market trends.
NewGenIvf |
NewGenIvf Provides Update on Potential Reverse Merger with COVIRIX StockTitan
Read at news.google.com
 |
NewGenIvf Group Fundamental Analysis
We analyze NewGenIvf Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NewGenIvf Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NewGenIvf Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
NewGenIvf Group is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
NewGenIvf Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NewGenIvf Group stock to make a market-neutral strategy. Peer analysis of NewGenIvf Group could also be used in its relative valuation, which is a method of valuing NewGenIvf Group by comparing valuation metrics with similar companies.
Peers
NewGenIvf Group Related Equities
| ATIP | ATI Physical | 9.68 | ||||
| ARDT | Ardent Health | 0.97 | ||||
| TOI | Oncology Institute | 0.41 | ||||
| FMS | Fresenius Medical | 0.13 | ||||
| AUNA | Auna SA | 0.72 | ||||
| GRDN | Guardian Pharmacy | 1.77 | ||||
| RHE | Regional Health | 1.80 | ||||
| PACS | PACS Group, | 2.63 | ||||
| RHE-PA | Regional Health | 7.89 |
Additional Tools for NewGenIvf Stock Analysis
When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.